Thurston Springer Miller Herd & Titak’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	1,007 +924	+1,113%	+$199K	0.09%	214
2026 Q1	$16.8K	Hold	83	–	–	0.01%	807
2025 Q4	$17.3K	Buy	83 +60	+261%	+$12K	0.01%	789
2025 Q3	$4.15K	Sell	23 -1,234	-98%	-$210K	0.01%	431
2025 Q2	$203K	Sell	1,257 -8	-0.6%	-$1.27K	0.03%	365
2025 Q1	$216K	Buy	1,265 +62	+5%	+$10.8K	0.04%	317
2024 Q4	$200K	Sell	1,203 -7,363	-86%	-$1.26M	0.04%	278
2024 Q3	$1.47M	Buy	8,566 +26	+0.3%	+$4.3K	0.41%	61
2024 Q2	$1.32M	Buy	+8,540	New	+$1.28M	0.41%	58

Other funds holding FBT

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

TWM

TriaGen Wealth Management Calabasas, California $400M AUM 39.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

OPAM

Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return

QCIG

Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

TCOO

Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's FBT Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1,113% in Q2 2026, buying an estimated $199K and bringing the position to 1,007 shares worth $250K. The position accounts for 0.09% of the portfolio, ranked #214.

Thurston Springer Miller Herd & Titak first reported a position in FBT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.47M in Q3 2024. 66 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Thurston Springer Miller Herd & Titak held 1,007 shares of First Trust NYSE Arca Biotechnology Index Fund worth $250K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 924 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $199K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #214 holding.
Thurston Springer Miller Herd & Titak first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.47M in Q3 2024.
66 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.